U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

By The Associated Press The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use ...

The vaccine is expected to remain available for anyone who is at least 65 or who has a medical condition, leaving many ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

The FDA's new vaccine guidelines focus on older adults, citing insufficient evidence for the need for additional COVID shots ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...

The approval came after Trump appointees overruled FDA scientists' earlier plans to approve the shot without restrictions.

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else — raising questions about whether some ...

WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional ...